share_log

Centogene Announces Initial Data From ROPAD Study Showing 90% Of Genetically Confirmed Parkinson's Patients Have LRRK2 Or GBA1 Variants; Findings Indicate 15% Of PD Cases Linked To Genetic Variants; Data Published In Brain Journal Highlights...

Benzinga ·  Aug 1 16:50

Centogene Announces Initial Data From ROPAD Study Showing 90% Of Genetically Confirmed Parkinson's Patients Have LRRK2 Or GBA1 Variants; Findings Indicate 15% Of PD Cases Linked To Genetic Variants; Data Published In Brain Journal Highlights Importance Of Genetic Testing In Gene-Targeted Trials

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment